Mackay Shields LLC’s Meridian Bioscience Inc VIVO Stock Holding History

Mackay Shields LLC’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-76,312	Closed	-$2M	–	1434
2021 Q1	$2M	Sell	76,312 -92,488	-55%	-$2.2M	0.01%	768
2020 Q4	$3.15M	Buy	168,800 +45,900	+37%	+$857K	0.02%	647
2020 Q3	$2.09M	Buy	122,900 +41,300	+51%	+$803K	0.01%	772
2020 Q2	$1.9M	Buy	81,600 +60,800	+292%	+$881K	0.02%	781
2020 Q1	$174K	Sell	20,800 -15,691	-43%	-$132K	﹤0.01%	1304
2019 Q4	$356K	Sell	36,491 -21,200	-37%	-$199K	﹤0.01%	1206
2019 Q3	$547K	Sell	57,691 -16,300	-22%	-$172K	﹤0.01%	1250
2019 Q2	$879K	Buy	+73,991	New	+$891K	0.01%	1162
2018 Q2	–	Sell	-31,400	Closed	-$446K	–	1323
2018 Q1	$446K	Buy	+31,400	New	+$465K	﹤0.01%	1132

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mackay Shields LLC's VIVO Position: Q2 2021 in Review

Mackay Shields LLC sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 76,312 shares — an estimated $2M sold.

Mackay Shields LLC first reported a position in VIVO in Q1 2018 and held it in 9 quarters. The position peaked at $3.15M in Q4 2020. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

Mackay Shields LLC reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
Mackay Shields LLC sold 76,312 Meridian Bioscience Inc shares in Q2 2021, an estimated $2M.
Mackay Shields LLC first reported a position in Meridian Bioscience Inc in Q1 2018 and held it in 9 quarters.
Mackay Shields LLC's Meridian Bioscience Inc position peaked at $3.15M in Q4 2020.
189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.